172 related articles for article (PubMed ID: 37881906)
1. Role of human papillomavirus (HPV) in cancers.
Khan A
S Afr Med J; 2023 Oct; 113(10):10. PubMed ID: 37881906
[No Abstract] [Full Text] [Related]
2. The time has come to implement primary human papillomavirus screening for cervical cancer in the United States.
Franco EL;
Cancer; 2023 Sep; 129(18):2765-2768. PubMed ID: 37347988
[No Abstract] [Full Text] [Related]
3. HPV vaccination in Southern Africa: A jab of hope in the fight against cervical cancer.
Michelow P; Firnhaber C
Cancer Cytopathol; 2016 Oct; 124(10):695-698. PubMed ID: 27182785
[No Abstract] [Full Text] [Related]
4. Coinfections in human papillomavirus associated cancers and prophylactic recommendations.
Ashok G; Basu S; Priyamvada P; Anbarasu A; Chintala S; Ramaiah S
Rev Med Virol; 2024 Mar; 34(2):e2524. PubMed ID: 38375992
[TBL] [Abstract][Full Text] [Related]
5. In 30 years, gender-neutral vaccination eradicates oncogenic human papillomavirus (HPV) types while screening eliminates HPV-associated cancers.
Lehtinen M; Gray P; Louvanto K; Vänskä S
Expert Rev Vaccines; 2022 Jun; 21(6):735-738. PubMed ID: 35404177
[No Abstract] [Full Text] [Related]
6. Profile of human papillomavirus genotypes in breast and oesophageal cancer patients in Pretoria, South Africa.
Maroga N; Mokoena T; Ledibane N; Musekiwa A; Bida M; Kgomo M; Lebelo R
S Afr Med J; 2023 Jul; 113(7):49-54. PubMed ID: 37882039
[TBL] [Abstract][Full Text] [Related]
7. Human papilloma virus (HPV) vaccine and cervical cancer prevention in Africa.
Okonofua F; Edouard L; Isikhuemen M
Afr J Reprod Health; 2023 Dec; 27(12):9-14. PubMed ID: 38156603
[TBL] [Abstract][Full Text] [Related]
8. [Human papillomavirus infection and vaccination].
He ZH; Kou ZQ; Xu AQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Jan; 52(1):106-112. PubMed ID: 29334719
[TBL] [Abstract][Full Text] [Related]
9. HPV vaccines: what remains to be done? Interview by Lauren Constable.
Zur Hausen H
Expert Rev Vaccines; 2011 Nov; 10(11):1505-7. PubMed ID: 22043949
[No Abstract] [Full Text] [Related]
10. Understanding the proportion of cervical cancers attributable to HPV.
Brotherton JM; Budd AC; Saville M
Med J Aust; 2020 Feb; 212(2):63-64.e1. PubMed ID: 31909481
[No Abstract] [Full Text] [Related]
11. Variation in genital human papillomavirus infection prevalence and vaccination coverage among men and women in the USA.
Han JJ; Tarney CM; Song J
Future Oncol; 2017 Jun; 13(13):1129-1132. PubMed ID: 28589730
[TBL] [Abstract][Full Text] [Related]
12. The rationale for implementation of HPV testing in routine cervical screening in Romania.
Iancu LS; Ursu RG
Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):293-6. PubMed ID: 24340506
[No Abstract] [Full Text] [Related]
13. Sexually Transmitted Human Papillomavirus: Update in Epidemiology, Prevention, and Management.
Plotzker RE; Vaidya A; Pokharel U; Stier EA
Infect Dis Clin North Am; 2023 Jun; 37(2):289-310. PubMed ID: 37105644
[TBL] [Abstract][Full Text] [Related]
14. Mathematical model of HPV provides insight into impacts of risk factors and vaccine.
Kim JJ
PLoS Med; 2006 May; 3(5):e164. PubMed ID: 16573363
[TBL] [Abstract][Full Text] [Related]
15. Distribution of Human Papillomavirus (HPV) Genotypes in HIV-Negative and HIV-Positive Women with Cervical Intraepithelial Lesions in the Eastern Cape Province, South Africa.
Taku O; Mbulawa ZZA; Phohlo K; Garcia-Jardon M; Businge CB; Williamson AL
Viruses; 2021 Feb; 13(2):. PubMed ID: 33670231
[TBL] [Abstract][Full Text] [Related]
16. Knowledge of cervical cancer and the HPV vaccine.
Paniagua H
Br J Nurs; 2006 Feb 9-22; 15(3):126-7. PubMed ID: 16493315
[No Abstract] [Full Text] [Related]
17. Current clinical trials of HPV vaccines.
Trimble EL; Schoenfeldt M
Oncology (Williston Park); 2004 Jun; 18(7):859-60, 862. PubMed ID: 15255170
[No Abstract] [Full Text] [Related]
18. Introducing human papillomavirus vaccines into the health system in South Africa.
Botha MH; Dochez C
Vaccine; 2012 Sep; 30 Suppl 3():C28-34. PubMed ID: 22939017
[TBL] [Abstract][Full Text] [Related]
19. Distribution of HPV types associated with cervical cancers in Scotland and implications for the impact of HPV vaccines.
Cuschieri K; Brewster DH; Williams AR; Millan D; Murray G; Nicoll S; Imrie J; Hardie A; Graham C; Cubie HA
Br J Cancer; 2010 Mar; 102(5):930-2. PubMed ID: 20145611
[TBL] [Abstract][Full Text] [Related]
20. Prevention strategies of cervical cancer in the HPV vaccine era.
Bosch X; Harper D
Gynecol Oncol; 2006 Oct; 103(1):21-4. PubMed ID: 16919714
[No Abstract] [Full Text] [Related]
[Next] [New Search]
